ExoXpert’s Post

Engineering mAbs for developability? This is how you do it. Our white-paper with Kaare Bjerregaard-Andersen from Lundbeck and Brunner Cyrill from Bruker Daltonics and the ATUM team walks through a nice example of a multiparametric and empirical #machinelearning (ML) approach to holistically engineer lead molecules into drugs. Check it out. https://lnkd.in/gMcRvMCF atum.bio #mAbs #ATUM Bioprocess Online

🎦 Upcoming live webinar: Unlock Multi-Omic Strategies to Accelerate Clinical Trial Success 📅 February 20, 2025 at 11 AM EST | 4 PM GMT 🔖 Secure your spot: https://lnkd.in/grdkABSQ We will be exploring how multi-omic approaches are accelerating precision medicine clinical trials, improving efficiency, and maximizing success rates. Featured speaker: Dr Francesca Barone, MD, PhD, Chief Scientific Officer at Candel Therapeutics, will share her expert insights and real-world applications of multi-omic data integration. Key highlights: - Optimizing trial design using multi-omics data to maximize success - Real-world examples showcasing improved outcomes - Overcoming hurdles like tumor heterogeneity, drug resistance, and data fragmentation #Biotech #ClinicalTrials #PrecisionMedicine #MultiOmics #Webinar #Sonrai #SonraiDiscovery #DrugDevelopment

We’re excited to announce the launch of our new website, which reflects our focus and commitment on developing novel, small molecule therapeutics for #immune diseases. At DeepCure, we're tackling the toughest challenges in #drugdiscovery with our groundbreaking AI-powered platforms. Discover how our proprietary #PocketExpander™ technology maps protein surfaces to identify novel interaction features, allowing us to design molecular glues that stabilize protein-protein interactions and pursue targets with no known ligand. Using MolGen™, we can generate custom, lead-like molecules from vast chemical spaces, all while ensuring synthetic feasibility and optimal ADME-Tox profiles. And with DiscoveryHub™, our research teams turn AI-driven designs into testable compounds efficiently, accelerating timelines. Explore the full capabilities of our technologies and how we’re pushing the boundaries of small molecule discovery: https://www.deepcure.ai

Did you miss it? 👀 Find out about the newly launched imaging suite and advanced lung Fibroblast-to-Myofibroblast Transition (FMT) assay. Comprising high-content and high-throughput equipment, the state-of-the-art imaging suite provides more in-depth and robust in vitro data. The advanced high-throughput high-sensitivity lung FMT assay facilitates rapid assessment of the efficacy of anti-fibrotic drug candidates enabling easy screening of libraries of compounds. 💬 “The launch of our new imaging suite and accompanying assay is a key step in continuing to provide innovative, market-leading in vitro models that advance the discovery and safe development of new drugs." - Dr Mike Nicholds, CEO and Co-Founder Learn more about our exciting new launch here: https://lnkd.in/gNBAEP3e #Newcells #DrugDevelopment #FMT #InVitroData

Attended and convened with key opinion leaders in Organ modelling, 3D cell culture, and mimics. These events are addressing a crucial and expanding field in drug development. The potential of Organ-on-a-Chip, Tissue-on-a-Chip, and Organoids is remarkable as they can better predict drug efficacy and significantly reduce costs. Check out the link below to learn more about the Organ Modelling and 3D Cell Culture event happening in 2024. https://lnkd.in/eCKyk-Uy

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification

How do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused? The newest member of the ÄKTA ready platform: ÄKTA ready 450 system Get a demo now! >> https://cytiva.link/njg3d #genetherapy #viralvectors #viralvectorpurification